Thursday, 9 April 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 09 April 2026
News

Off-label scripts for kids soaring

Posted 24 July 2025 PM

Prescribers are writing scripts for Ozempic for patients under the age of 18 years despite it not being approved for that age group, in the most egregious example of off-label prescribing of the drug.

PBS data provided by the Department of Health and Aged Care revealed that between July 2020, when Ozempic was first listed on the PBS, and June 2024 more than 2,832 scripts for the diabetes drug were written for people under 18 years of age.

To see the whole article, please login

Popular

Trump tariffs unleash hidden chaos
What Chat says about your drugs
Four brands hit with price cuts
Marketers 'not quite up to notch'
Latest Jobs
Pharma in Focus  Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home